title: A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor.
abstract: In this report, the genomic DNA was examined from two siblings with gonadal LH resistance. A 46,XY pseudohermaphrodite presented with female external genitalia and his 46,XX sister exhibited menstrual irregularities (oligoamenorrhea) and infertility. Exons 1-11 of the LH receptor (LHR) gene were amplified by the PCR using different sets of intronic primers and were directly sequenced. Sequencing revealed that both individuals carried a deletion of nucleotides 1822-1827, resulting in the deletion of Leu-608 and Val-609 within the seventh transmembrane helix. This mutation was introduced into a recombinant human (h) LHR cDNA. Transfections of 293 cells with hLHR(wt) vs. hLHR(deltaL608,V609) revealed that very little of the mutant receptor was expressed at the cell surface. This was due to both a decrease in the total amount of receptor expressed as well as to an increased intracellular retention of the mutant receptor. In spite of the decreased cell surface expression of the mutant, sufficient amounts were present to allow for assessment of its functions. Equilibrium binding assays showed that the cell surface hLHR(deltaL608,V609) binds hCG with an affinity comparable to that of the wild-type receptor. However, the cells expressing the hLHR(deltaL608,V609) exhibit only a 1.5- to 2.4-fold stimulation of cAMP production in response to hCG. In contrast, cells expressing comparably low levels of hLHR(wt) responded to hCG with 11- to 30-fold increases of cAMP levels. Therefore, the testicular and ovarian unresponsiveness to LH in these patients appears to be due to a mutation of the hLHR gene in which Leu-608 and Val-609 are deleted. As a consequence, the majority of the mutant receptor is retained intracellularly. The small percentage of mutant receptor that is expressed at the cell surface binds hormone normally but is unable to activate Gs.
authors.affiliation: Hospital das Clínicas, Unidade de Endocrinologia do Desenvolvimento, Universidade de São Paulo, Brazil. anacl@usp.br
authors.forename: A C
authors.initials: AC
authors.lastname: Latronico
authors.forename: Y
authors.initials: Y
authors.lastname: Chai
authors.forename: I J
authors.initials: IJ
authors.lastname: Arnhold
authors.forename: X
authors.initials: X
authors.lastname: Liu
authors.forename: B B
authors.initials: BB
authors.lastname: Mendonca
authors.forename: D L
authors.initials: DL
authors.lastname: Segaloff
mesh_terms: D000328:Adult; D000568:Amenorrhea / Q000235:genetics; D002462:Cell Membrane / Q000378:metabolism; D006063:Chorionic Gonadotropin / Q000378:metabolism / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D012734:Disorders of Sex Development / Q000235:genetics; D005260:Female; D006720:Homozygote; D006801:Humans; D008297:Male; D009154:Mutation; D010053:Ovary / Q000503:physiopathology*; D010375:Pedigree; D011974:Receptors, LH / Q000235:genetics* / Q000378:metabolism*; D017422:Sequence Analysis, DNA; D017384:Sequence Deletion; D015398:Signal Transduction; D013737:Testis / Q000503:physiopathology*; D014162:Transfection
chemical_list: D006063:Chorionic Gonadotropin; D011974:Receptors, LH; D000242:Cyclic AMP